New drugs for crystal deposition diseases.
McCarthy
Geraldine
G
D002114:Calcinosis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D017610:Calcium Compounds / Q000037:antagonists & inhibitors / Q000378:metabolism; D002951:Citrates / Q000494:pharmacology / Q000627:therapeutic use; D006073:Gout / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D006074:Gout Suppressants / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007596:Joints / Q000187:drug effects* / Q000473:pathology / Q000503:physiopathology; D010003:Osteoarthritis / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D014527:Uric Acid / Q000037:antagonists & inhibitors / Q000097:blood
D017610:Calcium Compounds; D002951:Citrates; D006074:Gout Suppressants; C014148:phosphocitrate; D014527:Uric Acid